The Big Shift in Medicine: Why Tracking Every Pill Just Became Law
As of late 2025, every individual package of brand-name or generic medicine moving through the United States must be tracked at the unit level. This shift transforms how biotechnology and pharmaceutical firms manage operations. For companies like DES Pharma, building a bulletproof, highly visible supply chain is no longer solely a smart business strategy—it is the law.
Continuous Manufacturing and ICH Q13: Regulatory Readiness at Scale
Guided by the landmark ICH Q13 guidelines, the global pharmaceutical industry is undergoing a revolutionary shift from traditional batch manufacturing to agile, continuous production systems. Read this Week's Guard Rail to explore the revolutionary shift from traditional batch manufacturing to agile, continuous production systems.
ICH Q12: Post-Approval Change Management for Pharmaceutical Product Lifecycle Management
The formalized roll-out of ICH Q12 mechanisms introduces an organized approach to identifying and managing regulatory commitments. This framework allows manufacturers to execute routine modifications under the oversight of their internal Pharmaceutical Quality System (PQS), reducing the burden of prior-approval regulatory filings.
AI in Regulatory Submissions: Writing for Both Human and Machine Reviewers
This week in the Guardrail, we analyze the dual-audience reality facing modern pharmaceutical compliance. As regulatory agencies integrate automated tools to parse complex submissions, drug sponsors must adapt their documentation strategies to satisfy both algorithmic logic and human expertise.